|
Volumn 65, Issue 5, 1999, Pages 483-491
|
Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene
|
Author keywords
C6 cells; GFAP promoter; Parkinson's disease; Transplants; Tyrosine hydroxylase
|
Indexed keywords
APOMORPHINE;
COMPLEMENTARY DNA;
FORSKOLIN;
GLIAL FIBRILLARY ACIDIC PROTEIN;
OXIDOPAMINE;
TYROSINE 3 MONOOXYGENASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
GENE THERAPY;
GLIOMA CELL;
NONHUMAN;
PARKINSON DISEASE;
PROMOTER REGION;
RAT;
TRANSGENE;
ANIMALS;
CELL TRANSPLANTATION;
GENE THERAPY;
GLIAL FIBRILLARY ACIDIC PROTEIN;
GLIOMA;
HUMANS;
MALE;
OXIDOPAMINE;
PARKINSON DISEASE, SECONDARY;
RATS;
RATS, WISTAR;
TUMOR CELLS, CULTURED;
TYROSINE 3-MONOOXYGENASE;
ANIMALIA;
RODENTIA;
|
EID: 0033603193
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(99)00269-6 Document Type: Article |
Times cited : (17)
|
References (23)
|